Crystal structure of the mitochondrial protein mitoNEET bound to a benze-sulfonide ligand
- West Virginia Univ., Morgantown, WV (United States)
- Marshall Univ., Huntington, WV (United States)
- Nippon Medical School, Sendagi, Tokyo (Japan)
- Ball State Univ., Muncie, IN (United States)
- Univ. of Louisville, KY (United States)
- West Virginia Univ., Morgantown, WV (United States); Modulation Therapeutics, Morgantown, WV (United States)
MitoNEET (gene cisd1) is a mitochondrial outer membrane [2Fe-2S] protein and is a potential drug target in several metabolic diseases. Previous studies have demonstrated that mitoNEET functions as a redox-active and pH-sensing protein that regulates mitochondrial metabolism, although the structural basis of the potential drug binding site(s) remains elusive. Here we report the crystal structure of the soluble domain of human mitoNEET with a sulfonamide ligand, furosemide. Exploration of the high-resolution crystal structure is used to design mitoNEET binding molecules in a pilot study of molecular probes for use in future development of mitochondrial targeted therapies for a wide variety of metabolic diseases, including obesity, diabetes and neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- National Institute of Health (NIH); National Institute of General Medical Sciences (NIGMS); Office of Research Infrastructure Programs (ORIP); USDOE Office of Science (SC); Ohio Valley Whipkey Trust
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1557303
- Journal Information:
- Communications Chemistry, Journal Name: Communications Chemistry Journal Issue: 1 Vol. 2; ISSN 2399-3669
- Publisher:
- Springer NatureCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Mutation of the His ligand in mitoNEET stabilizes the 2Fe–2S cluster despite conformational heterogeneity in the ligand environment
New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer’s disease